Sterlite Technologies has secured a ₹960 crore telecom cable contract, while Zee Entertainment and its top leaders face a ₹1.48 crore penalty from SEBI. Meanwhile, HCL Technologies finalized its acquisition of Guardian India to expand its global capability unit. Investors are tracking these varied corporate updates as auto stocks also remain in focus following strong July sales numbers.
A series of significant corporate developments is shaping investor sentiment on August 3, 2026, ranging from large contract wins and strategic acquisitions to regulatory actions.
Sterlite Technologies Secures Telecom Order
Sterlite Technologies Limited has announced a new order worth ₹960 crore from a domestic telecom operator. The contract involves the supply of optical fibre cables over the next two years. For shareholders, this order is meaningful as it provides a clear revenue visibility for the company through FY28 and FY29. The company has also included an option to extend this agreement, which could further support long-term order books if exercised.
Regulatory Action at Zee Entertainment
The Securities and Exchange Board of India (SEBI) has imposed a penalty of ₹1.48 crore on Zee Entertainment Enterprises Limited (ZEEL). The regulator also issued a one-year ban from the securities market against CEO Punit Goenka and Founder-Chairman Emeritus Subhash Chandra for violations of securities laws. This regulatory development is a material event as it impacts the company’s leadership and governance, which investors typically monitor closely to assess potential risks to management stability and long-term business strategy.
HCL Technologies Expansion
HCL Technologies has officially completed its acquisition of Guardian India Operations Private Limited. This transaction, which took effect on July 31, 2026, allows HCL to integrate a captive Global Capability Centre (GCC) into its operations. By bringing approximately 2,000 employees into a new strategic business unit, the company is looking to strengthen its service delivery capabilities. Investors may watch how this integration impacts the company’s operational costs and service margins in upcoming quarters.
Healthcare Sector Developments
In the pharmaceutical space, Dr. Reddy’s Laboratories received approval from the U.S. Food and Drug Administration (FDA) for its rituximab biosimilar, marking an expansion of its international product portfolio. Additionally, Zydus Lifesciences received a positive 'Voluntary Action Indicated' (VAI) classification from the USFDA for its Ahmedabad injectable facility, which removes a regulatory hurdle for that plant. Lupin Limited also secured US FDA approval for its Sugammadex injection, further adding to the sector's news flow.
Broader Corporate Updates
Several other companies reported significant updates. Varun Beverages is expanding its international footprint by acquiring a beverage business in Kenya for approximately ₹305 crore ($32 million). Meanwhile, Uflex Limited has started commercial production at its new manufacturing plant in Mexico, which has an annual capacity of 80 million bags. In the energy sector, KP Energy and Powerica have signed Power Purchase Agreements with GUVNL for wind projects, while Waaree Energies secured a large solar module supply order for 739.71 MW. Investors should monitor the execution timelines for these new projects, as any delays or cost increases can impact profit margins.